ApprovalTrail

Approval · Notice of Compliance 4088 · 1997

RYLOSOL: Notice of Compliance 4088

Issued February 6, 1997

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
4088
Date
February 6, 1997
Company
Icn Canada Ltd.Montreal, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Other
Therapeutic class
Anti-arrhythmic
Canadian reference product
SOTACOR (Bristol Laboratories Of Canada)

Products in this notice

BrandDINStatus today
RYLOSOL02230649Cancelled Post Market
RYLOSOL02230650Cancelled Post Market
RYLOSOL02230651Cancelled Post Market

Medicinal ingredients